Author

C. Barone

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. Gupta· 1 shared A. S. Piotrowski-Daspit· 1 shared A. S. Ricciardi· 1 shared C.-Y. Lin· 1 shared D. Wu· 1 shared E. Xu· 1 shared F. Alessandrini· 1 shared I. Sambruni· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Gupta

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

In vivo correction of cystic fibrosis mediated by PNA nanoparticles

A. S. Piotrowski-Daspit, C. Barone, C.-Y. Lin, Y. Deng, D. Wu, T. C. Binns, E. Xu, A. S. Ricciardi, R. Putman, R. Nguyen, A. Gupta, R. Fan, P. Glazer, W. M. Saltzman, M. E. Egan

This study demonstrates systemic gene editing using PNA nanoparticles to correct the F508del CFTR mutation in mice, showing partial CFTR function restoration and tissue-specific correction without off-target effects.

bioRxiv · Jan 28, 2022Bioengineering

Sox2-dependent maintenance of mouse oligodendroglioma involves the Sox2-mediated downregulation of Cdkn2b, Ebf1, Zfp423 and Hey2

C. Barone, M. Buccarelli, F. Alessandrini, M. Pagin, L. Rigoldi, I. Sambruni, R. Favaro, S. Ottolenghi, R. Pallini, L. Ricci-Vitiani, P. Malatesta, S. K. Nicolis

This study identifies four genes, Cdkn2b, Ebf1, Zfp423, and Hey2, whose inhibition by Sox2 is critical for maintaining glioma cancer stem cell properties, suggesting new therapeutic targets.

bioRxiv · Mar 4, 2020Cancer Biology